Inhibition of Hepatitis B Virus Replication by Drug-Induced Depletion of Nucleocapsids
Top Cited Papers
- 7 February 2003
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 299 (5608) , 893-896
- https://doi.org/10.1126/science.1077215
Abstract
Chronic hepatitis B virus (HBV) infection is a major cause of liver disease. Only interferon-α and the nucleosidic inhibitors of the viral polymerase, 3TC and adefovir, are approved for therapy. However, these therapies are limited by the side effects of interferon and the substantial resistance of the virus to nucleosidic inhibitors. Potent new antiviral compounds suitable for monotherapy or combination therapy are highly desired. We describe non-nucleosidic inhibitors of HBV nucleocapsid maturation that possess in vitro and in vivo antiviral activity. These inhibitors have potential for future therapeutic regimens to combat chronic HBV infection.Keywords
This publication has 12 references indexed in Scilit:
- Characterization of binding interactions by isothermal titration calorimetryPublished by Elsevier ,2002
- Inhibition of human hepatitis B virus (HBV) by a novel non-nucleosidic compound in a transgenic mouse modelAntiviral Research, 2001
- Lamivudine resistance in hepatitis B: mechanisms and clinical implicationsDrug Resistance Updates, 2001
- Resistance of Hepatitis B Virus to Antiviral Drugs: Current Aspects and Directions for Future InvestigationAntiviral Chemistry and Chemotherapy, 2001
- Development of resistance and perspectives for future therapies against hepatitis B infections: Lessons to be learned from HIVInfection, 1999
- Inhibition of Human Hepatitis B Virus Replication by AT-61, a Phenylpropenamide Derivative, Alone and in Combination with (−)β- l -2′,3′-Dideoxy-3′-ThiacytidineAntimicrobial Agents and Chemotherapy, 1998
- Hepatitis B Virus MorphogenesisPublished by Springer Nature ,1996
- Precore-mediated inhibition of hepatitis B virus progeny DNA synthesisJournal of Virology, 1993
- The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assemblyJournal of Virology, 1992
- Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA.Proceedings of the National Academy of Sciences, 1987